Cox v. Danos, L.L.C.

CourtDistrict Court, E.D. Louisiana
DecidedJuly 8, 2025
Docket2:24-cv-02313
StatusUnknown

This text of Cox v. Danos, L.L.C. (Cox v. Danos, L.L.C.) is published on Counsel Stack Legal Research, covering District Court, E.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cox v. Danos, L.L.C., (E.D. La. 2025).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA

ERNEST COX CIVIL ACTION

VERSUS NO. 24-2313

DANOS, LLC, et al. SECTION: “G”(4)

ORDER AND REASONS Before the Court is Defendant Chevron USA, Inc.’s (“Chevron”) Rule 12(b)(6) Motion to Dismiss.1 Chevron argues that Plaintiff Ernest Cox’s (“Plaintiff”) claims against it are grounded in allegations insufficient to raise a right to relief beyond a speculative level.2 In opposition, Plaintiff argues he has presented sufficient factual allegations for each cause of action to survive this Motion to Dismiss.3 Having considered the motion, the memoranda in support and opposition, the record, and the applicable law, this Court denies the motion without prejudice and grants Plaintiff leave to file an amended complaint. I. Background Plaintiff brings claims against Defendants Danos, LLC (“Danos”) and Chevron (collectively “Defendants”) for alleged violations of Title VII of the Civil Rights Act of 1964 (“Title VII”), the Americans with Disabilities Act (“ADA”), and the Family and Medical Leave

1 Rec. Doc. 14. 2 Id. 3 Rec. Doc. 22. Act (“FMLA”).4 Plaintiff was employed by Danos between 2008 and 2012, again between 2019 and 2020, and again between 2021 and 2023.5 While employed by Danos from 2008 through 2012, Plaintiff was contracted to work with Chevron.6 In 2012, Plaintiff claims Chevron revealed its interest in hiring Plaintiff, but Plaintiff did not apply due to his father passing away.7 Plaintiff chose to resign from Danos as an employee

in 2012.8 In 2019, Plaintiff was hired by Danos again to contract with Arena Offshore.9 In 2020, as part of this work, Plaintiff responded to a capsized ship where several people were lost at sea.10 Plaintiff claims he was traumatized from this incident and experienced panic attacks and began suffering from Post Traumatic Stress Disorder and Depression.11 Plaintiff was granted one month of leave under the FMLA and was subsequently terminated by Danos after returning to work.12 In late 2021, Chevron inquired about having Plaintiff work for them through Danos.13 Danos rehired Plaintiff, and Plaintiff was assigned to work for Chevron as a Planner Scheduler.14

4 Rec. Doc. 11-1 at 1. 5 Id. at 4–6. 6 Id. at 4. 7 Id. 8 Id. 9 Id. 10 Id. 11 Id. 12 Id. 13 Id. 14 Id. at 4–5. On November 11, 2022, Plaintiff was charged with a misdemeanor, and he was later found guilty of simple battery.15 Plaintiff claims he let his immediate supervisor, Garrett Gamberi of Chevron (“Supervisor Gamberi”), know of this charge.16 In January 2023, Plaintiff claims that Chevron Manager Nathan Taylor (“Manager Taylor”) recommended he apply for the Logistics Coordinator position.17 Plaintiff asserts he interviewed for this position in March 2023 and was

offered the position in May 2023, with a June 5, 2023 start date.18 In March 2023, Plaintiff alleges he was diagnosed with aspirin-exacerbated respiratory disease (“AERD”), a chronic medical condition that includes asthma, recurrent nasal polyps, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (“NSAID”).19 Plaintiff claims he let Supervisor Gamberi know of the condition.20 In May 2023, Plaintiff was prescribed a new Flonase nasal spray for his AERD.21 He used it for the first time while working offshore on the Chevron Genesis platform.22 Within five to ten minutes, Plaintiff began suffering from numbness and tingling.23 Plaintiff asserts he sought treatment with the medical nurse, Preston Dedeaux (“Nurse Dedeaux”).24 Plaintiff claims Nurse

15 Id. 16 Id. 17 Id. at 6. 18 Id. 19 Id. 20 Id. 21 Id. 22 Id. 23 Id. 24 Id. Dedeaux found him in a hypertensive crisis due to his elevated blood pressure and contacted the Chevron Emergency Medical Team.25 The next day, Plaintiff returned to shore and sought treatment with his primary care doctor, who Plaintiff alleges found the nasal spray had a binding agent that caused an allergic reaction in Plaintiff.26 After Plaintiff returned home, Chevron requested that he take a drug test.27 Plaintiff claims,

unbeknownst to him, Nurse Dedeaux searched Plaintiff’s locker and found Plaintiff’s prescription medication and a black vial.28 Plaintiff claims Nurse Dedeaux assumed that Plaintiff was snorting his prescription medication, and Nurse Dedeaux began spreading rumors throughout Chevron that Plaintiff was “clinically crazy” and a “drug addict.”29 Upon returning to Chevron’s Genesis Platform for work, Plaintiff claims fellow employees ostracized him, and he was informed Nurse Dedeaux had spread these rumors about him.30 Plaintiff says he reported Nurse Dedeaux’s conduct to Supervisor Gamberi.31 Plaintiff asserts Supervisor Gamberi informed Plaintiff that Nurse Dedeaux would be terminated.32 However, Plaintiff alleges Nurse Dedeaux was allowed to continue working with Chevron at an alternate Chevron facility.33

On June 2, 2023, Plaintiff alleges he sought medical treatment for stomach pains and was

25 Id. 26 Id. 27 Id. at 7. 28 Id. 29 Id. 30 Id. at 7–8. 31 Id. at 8. 32 Id. 33 Id. later informed he needed his appendix removed.34 At that point, Plaintiff filed for FMLA leave and short term disability, and he was put on medical leave.35 On June 16, 2023, while still on medical leave, Plaintiff discovered he had an enlarged spleen, enlarged lymph node, and possible leukemia lymphoma.36 Plaintiff avers he alerted Chevron HR and his manager of these possible conditions.37 Plaintiff claims, on June 23, 2023, Chevron HR representative Sophia Milagros

Abascal rescinded his offer of employment with Chevron “based on whole or in part on the consumer or investigative consumer report mailed to you on June 5, 2023.”38 Plaintiff then returned to work for Danos, but he was terminated on August 13, 2023.39 Based on these events, Plaintiff alleges he was subject to a hostile work environment, disability discrimination, interference with his FMLA rights, and retaliation under both the ADA and the FMLA.40 On November 29, 2023, Plaintiff filed a Charge of Discrimination against Chevron and Danos with the EEOC.41 On September 23, 2024, Plaintiff filed this action before this Court, and he filed an Amended Complaint on December 13, 2024.42 On January 21, 2025, Chevron filed this

34 Id. 35 Id. 36 Id. at 9. 37 Id. 38 Id. 39 Id. at 10. 40 Id. at 24–33. 41 Id. at 30. 42 Rec. Doc. 1; Rec. Doc. 11. Motion to Dismiss under Rule 12(b)(6).43 Plaintiff filed an opposition on February 12, 2025.44 Chevron filed a reply on February 18, 2025.45 II. Parties’ Arguments A. Chevron’s Arguments in Support of the Motion to Dismiss Chevron asserts Plaintiff’s claims against it under the ADA and FMLA are based on

conclusory allegations that Danos and Chevron unlawfully discriminated and retaliated against Plaintiff.46 Chevron raises five arguments in support of its motion. First, Chevron argues for dismissal of Plaintiff’s claim against it for a hostile work environment under the ADA.47 Chevron argues the alleged harassment Plaintiff experienced was not based on his disabilities, which include depression, PTSD, and AERD.48 Chevron avers Plaintiff’s alleged unwanted harassment was based on rumors created by Nurse Dedeaux.49 Chevron also contends the alleged harassment was “slight, at best” and thus not severe or pervasive enough to affect a term, condition, or privilege of Plaintiff’s employment.50 Chevron further asserts the alleged ostracism was short lived, only taking place over the course of two weeks from Plaintiff’s medical incident until Plaintiff took medical leave.51 Chevron states it took prompt,

43 Rec. Doc. 14. 44 Rec. Doc. 22. 45 Rec. Doc. 38. 46 Rec. Doc. 14-1 at 1. 47 Id. at 8. 48 Id. 49 Id. 50 Id. at 9. 51 Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carbe v. Lappin
492 F.3d 325 (Fifth Circuit, 2007)
Lormand v. US Unwired, Inc.
565 F.3d 228 (Fifth Circuit, 2009)
Harris v. Forklift Systems, Inc.
510 U.S. 17 (Supreme Court, 1993)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Susan Waltman v. International Paper Co.
875 F.2d 468 (Fifth Circuit, 1989)
Gerald Caldwell v. KHOU-TV
850 F.3d 237 (Fifth Circuit, 2017)
Timothy Patton v. Jacobs Engineering Group, Inc, e
874 F.3d 437 (Fifth Circuit, 2017)
Cuellar v. Keppel Amfels, L.L.C.
731 F.3d 342 (Fifth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Cox v. Danos, L.L.C., Counsel Stack Legal Research, https://law.counselstack.com/opinion/cox-v-danos-llc-laed-2025.